Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben Bill

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
FEBS Letters|May 17, 2015
The relevance of EMT in breast cancer metastasis: Correlation or causality?Ruben Bill, Gerhard Christofori
Therapeutische Umschau. Revue Therapeutique|September 10, 2019
[Immunotherapies - Overview, mode of action and clinical implications]Ruben Bill, Julian Schardt
Methods in Molecular Biology (Clifton, N.J.)|November 19, 2016
The Rip1Tag2 Transgenic Mouse ModelRuben Bill, Gerhard Christofori
Journal of Neuroimmunology|November 6, 2010
PSGL-1 is dispensible for the development of active experimental autoimmune encephalomyelitis in SJL/J miceRuben Bill, Axinia Döring, Urban Deutsch, et al.
Head and Neck Pathology|November 6, 2023
Assessing PD-L1 Expression in Head and Neck Squamous Cell Carcinoma: Trials and TribulationsRuben Bill, William C Faquin, Sara I Pai
Journal of Cancer Research and Clinical Oncology|December 3, 2024
Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinomaFrancesca Huwyler, Roland Giger, Ruben Bill, et al.
Angiogenesis|May 30, 2015
An immature B cell population from peripheral blood serves as surrogate marker for monitoring tumor angiogenesis and anti-angiogenic therapy in mouse modelsErnesta Fagiani, Ruben Bill, Laura Pisarsky, et al.
Angiogenesis|April 3, 2016
VEGF receptor-2-specific signaling mediated by VEGF-E induces hemangioma-like lesions in normal and in malignant tissueErnesta Fagiani, Pascal Lorentz, Ruben Bill, et al.
Journal of Mammary Gland Biology and Neoplasia|September 14, 2018
A Transgenic MMTV-Flippase Mouse Line for Molecular Engineering in Mammary Gland and Breast Cancer Mouse ModelsFabiana Lüönd, Ruben Bill, Andrea Vettiger, et al.
Journal for Immunotherapy of Cancer|March 3, 2025
Chrono-immunotherapy as a low-hanging fruit for cancer treatment? A call for pragmatic randomized clinical trialsBerna C Özdemir, Ruben Bill, Alper Okyar, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
FEBS Letters|May 17, 2015
The relevance of EMT in breast cancer metastasis: Correlation or causality?Ruben Bill, Gerhard Christofori
Therapeutische Umschau. Revue Therapeutique|September 10, 2019
[Immunotherapies - Overview, mode of action and clinical implications]Ruben Bill, Julian Schardt
Methods in Molecular Biology (Clifton, N.J.)|November 19, 2016
The Rip1Tag2 Transgenic Mouse ModelRuben Bill, Gerhard Christofori
Journal of Neuroimmunology|November 6, 2010
PSGL-1 is dispensible for the development of active experimental autoimmune encephalomyelitis in SJL/J miceRuben Bill, Axinia Döring, Urban Deutsch, et al.
Head and Neck Pathology|November 6, 2023
Assessing PD-L1 Expression in Head and Neck Squamous Cell Carcinoma: Trials and TribulationsRuben Bill, William C Faquin, Sara I Pai
Journal of Cancer Research and Clinical Oncology|December 3, 2024
Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinomaFrancesca Huwyler, Roland Giger, Ruben Bill, et al.
Angiogenesis|May 30, 2015
An immature B cell population from peripheral blood serves as surrogate marker for monitoring tumor angiogenesis and anti-angiogenic therapy in mouse modelsErnesta Fagiani, Ruben Bill, Laura Pisarsky, et al.
Angiogenesis|April 3, 2016
VEGF receptor-2-specific signaling mediated by VEGF-E induces hemangioma-like lesions in normal and in malignant tissueErnesta Fagiani, Pascal Lorentz, Ruben Bill, et al.
Journal of Mammary Gland Biology and Neoplasia|September 14, 2018
A Transgenic MMTV-Flippase Mouse Line for Molecular Engineering in Mammary Gland and Breast Cancer Mouse ModelsFabiana Lüönd, Ruben Bill, Andrea Vettiger, et al.
Journal for Immunotherapy of Cancer|March 3, 2025
Chrono-immunotherapy as a low-hanging fruit for cancer treatment? A call for pragmatic randomized clinical trialsBerna C Özdemir, Ruben Bill, Alper Okyar, et al.
Pageof 3